EXHIBIT 10.34
NOTE AND WARRANT PURCHASE
AGREEMENT
Dated as of February 5, 2007
by and among
COMMUNICATION INTELLIGENCE
CORPORATION
and
THE PURCHASERS LISTED ON EXHIBIT A
TABLE OF CONTENTS
Page
|
ARTICLE I PURCHASE AND SALE OF NOTES
AND WARRANTS
|
|
Section 1.1
|
Purchase and Sale of Notes and
Warrants.
|
1
|
|
Section 1.2
|
Execution and Borrowing
|
1
|
|
Section 1.3
|
Warrant Shares
|
2
|
|
ARTICLE II REPRESENTATIONS AND
WARRANTIES
|
|
Section 2.1
|
Representations and Warranties of
the Company
|
2
|
|
Section 2.2
|
Representations and Warranties of
the Purchasers
|
12
|
|
ARTICLE III COVENANTS
|
|
|
|
Section 3.1
|
Securities Compliance
|
14
|
|
Section 3.2
|
Registration and Listing
|
14
|
|
Section 3.3
|
Compliance with Laws
|
14
|
|
Section 3.4
|
Keeping of Records and Books of
Account
|
14
|
|
Section 3.5
|
Reporting Requirements
|
15
|
|
Section 3.6
|
Other Agreements
|
15
|
|
Section 3.7
|
Use of Proceeds
|
15
|
|
Section 3.8
|
Reporting Status
|
15
|
|
Section 3.9
|
Disclosure of Transaction
|
15
|
|
Section 3.10
|
Disclosure of Material
Information
|
16
|
|
Section 3.11
|
Amendments
|
16
|
|
Section 3.12
|
Reservation of Shares
|
16
|
|
Section 3.13
|
Disposition of Assets
|
16
|
|
Section 3.14
|
Non-Shorting
|
16
|
|
ARTICLE IV CONDITIONS
|
|
|
|
Section 4.1
|
Conditions Precedent to the
Obligation of the Company to Close and to Sell the
Securities
|
16
|
|
Section 4.2
|
Conditions Precedent to the
Obligation of the Purchasers to Close and to Purchase the
Securities
|
17
|
|
ARTICLE V CERTIFICATE
LEGEND
|
|
Section 5.1
|
Legend
|
18
|
|
ARTICLE VI
INDEMNIFICATION
|
|
Section 6.1
|
General Indemnity
|
19
|
|
Section 6.2
|
Indemnification Procedure
|
19
|
|
ARTICLE VII MISCELLANEOUS
|
|
Section 7.1
|
Fees and Expenses
|
20
|
|
Section 7.2
|
Specific Performance; Consent to
Jurisdiction; Venue
|
21
|
|
Section 7.3
|
Entire Agreement;
Amendment
|
21
|
|
Section 7.4
|
Notices
|
21
|
|
Section 7.5
|
Waivers
|
22
|
|
Section 7.6
|
Headings
|
22
|
|
Section 7.7
|
Successors and Assigns
|
22
|
|
Section 7.8
|
No Third Party
Beneficiaries
|
22
|
|
Section 7.9
|
Governing Law
|
22
|
|
Section 7.10
|
Survival
|
23
|
|
Section 7.11
|
Counterparts
|
23
|
|
Section 7.12
|
Publicity
|
23
|
|
Section 7.13
|
Severability
|
23
|
|
Section 7.14
|
Further Assurances
|
23
|
|
|
|
|
NOTE AND WARRANT PURCHASE AGREEMENT
This NOTE AND WARRANT PURCHASE AGREEMENT dated
as of February 5, 2007 (this “ Agreement ”) by
and between Communication Intelligence Corporation, a Delaware
corporation (the “ Company ”), and each of the
purchasers of the promissory notes of the Company whose names are
set forth on Exhibit A attached hereto (each a “
Purchaser ” and collectively, the “
Purchasers ”).
The parties hereto agree as follows:
ARTICLE I
PURCHASE AND SALE OF NOTES AND
WARRANTS
Section 1.1
Purchase and Sale of Notes and
Warrants .
(a)
Upon the following terms and
conditions, the Company shall issue and sell to the Purchasers, and
the Purchasers shall purchase from the Company, promissory notes in
the aggregate principal amount of up to Six Hundred Thousand
Dollars ($600,000) bearing interest at the rate of fifteen percent
(15%) per annum, in substantially the form attached hereto as
Exhibit B (the “Notes”). The Company and the Purchasers
are executing and delivering this Agreement in accordance with and
in reliance upon the exemption from securities registration
afforded by Section 4(2) of the U.S. Securities Act of 1933, as
amended, and the rules and regulations promulgated thereunder (the
“Securities Act”), including Regulation D
(“Regulation D”), and/or upon such other exemption from
the registration requirements of the Securities Act as may be
available with respect to any or all of the investments to be made
hereunder.
(b)
Upon the following terms and
conditions, the Purchasers shall be issued (i) Warrants, in
substantially the form attached hereto as Exhibit C (the
“ Warrants ”), to purchase the number of shares
of Common Stock set forth opposite such Purchaser’s name on
Exhibit A attached hereto. The Warrants shall have an
exercise price equal to the Warrant Price (as defined in the
respective Warrant) and shall be exercisable as stated therein.
Each Warrant shall have a term of three (3) years from the later of
i) the date it is issued (the “Issuance Date”) or ii)
June 30, 2007.
Section 1.2
Execution and
Borrowing
(a) The execution of this Agreement shall take place
at the offices of Davis Wright Tremaine LLP, 1300 S.W. Fifth
Avenue, 23 rd Floor, Portland, Oregon 97201 (the
“Execution”) at 10:00 a.m., Pacific Daylight Time (i)
on or before February 5, 2007; provided, that all of the conditions
set forth in Article IV hereof and applicable to the Closing shall
have been fulfilled or waived in accordance herewith, or (ii) at
such other time and place or on such date as the Purchasers and the
Company may agree upon (the “Execution
Date”).
(b) During the period commencing on the Execution
Date and terminating on March 31, 2007 (the Borrowing Period) and
subject to the terms and conditions of this Agreement, the Company
may issue and sell the Notes and Warrants to the Purchasers in an
amount not to exceed $600,000 (such amount, the “Purchase
Price”) by giving notice thereof to each Purchaser. Within
seven (7) business days of receipt of such notice, the Company
shall deliver or cause to be delivered to each Purchaser (x) its
Note for the amount of the Purchase Price being drawn upon and (y)
a Warrant to purchase the pro rata number of shares of Common Stock
corresponding to the Purchase Price (the maximum number of shares
to be issued pursuant to such warrants shall be 3,111,000 if the
full $600,000 in notes are issued) and each Purchaser shall deliver
its Purchase Price by wire transfer to an account designated by the
Company. Each Note issued under this Section 1.2 shall be due and
payable eighteen months after the date of issuance. If the Company
has not requested the full amount available, by March 31, 2007, the
Purchasers shall be entitled to receive, based upon the amount not
drawn to the amount available, a pro rata portion of 250,000 shares
of Common Stock as a standby commitment fee not later than April
30, 2007.
Section 1.3
Warrant Shares
. If at any time any Warrant is exercised and
the number of the shares available is insufficient to effect the
exercise, the Company shall seek authorization at the next
scheduled annual meeting of its shareholders to increase the number
of the shares available to effect the exercise of the Warrants and
shall reserve such number of shares for that purpose. Any shares of
Common Stock issuable upon exercise of the Warrants (and such
shares when issued) are herein referred to as the “Warrant
Shares.” The Notes, the Warrants and the Warrant Shares are
sometimes collectively referred to herein as the
“Securities”.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
Section 2.1
Representations and Warranties of
the Company
. The Company hereby represents and warrants to
the Purchasers, as of the date hereof and the Closing Date (except
as set forth on the Schedule of Exceptions attached hereto with
each numbered Schedule corresponding to the section number herein),
as follows:
(a)
Organization, Good Standing and
Power . The Company is a
corporation duly incorporated, validly existing and in good
standing under the laws of the State of Delaware and has the
requisite corporate power to own, lease and operate its properties
and assets and to conduct its business as it is now being
conducted. The Company does not have any Subsidiaries (as defined
in Section 2.1(g)) or own securities of any kind in any other
entity except as set forth on Schedule 2.1(g) hereto. The
Company and each such Subsidiary (as defined in Section 2.1(g)) is
duly qualified as a foreign corporation to do business and is in
good standing in every jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification
necessary except for any jurisdiction(s) (alone or in the
aggregate) in which the failure to be so qualified will not have a
Material Adverse Effect. For the purposes of this Agreement,
“ Material Adverse Effect ” means any effect on
the business (including a material change in management), results
of operations, prospects, properties, assets or condition
(financial or otherwise) of the Company that is material and
adverse to the Company and its subsidiaries, taken as a whole,
and/or any condition, circumstance, factor or situation (including,
without limitation, an investigation by the Securities and Exchange
Commission (the “ Commission ”)) that would
prohibit or otherwise materially interfere with the ability of the
Company from entering into and performing any of its obligations
under the Transaction Documents (as defined below) in any material
respect.
(b)
Authorization;
Enforcement . The Company
has the requisite corporate power and authority to enter into and
perform this Agreement, the Notes, the Warrants, the Registration
Rights Agreement by and among the Company and the Purchasers, dated
as of the date hereof, substantially in the form of Exhibit
E attached hereto (the “ Registration Rights
Agreement ”) (collectively, the “ Transaction
Documents ”) and to issue and sell the Securities in
accordance with the terms hereof. The execution, delivery and
performance of the Transaction Documents by the Company and the
consummation by it of the transactions contemplated thereby have
been duly and validly authorized by all necessary corporate action,
and, except as set forth on Schedule 2.1(b) , no further
consent or authorization of the Company, its Board of Directors or
stockholders is required. When executed and delivered by the
Company and each Purchaser, each of the Transaction Documents shall
constitute a valid and binding obligation of the Company
enforceable against the Company in accordance with its terms,
except as such enforceability may be limited by applicable
bankruptcy, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or
affecting generally the enforcement of, creditor’s rights and
remedies or by other equitable principles of general
application.
(c)
Capitalization
. The authorized capital stock of
the Company as of December 31, 2006 is set forth on Schedule
2.1(c) hereto. All of the outstanding shares of the Common
Stock and any other outstanding security of the Company have been
duly and validly authorized. Except as set forth in this Agreement
and as set forth on Schedule 2.1(c) hereto, no shares of
Common Stock or any other security of the Company are entitled to
preemptive rights or registration rights and there are no
outstanding options, warrants, scrip, rights to subscribe to, call
or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock
of the Company. Furthermore, except as set forth in this Agreement
and as set forth on Schedule 2.1(c) hereto, there are no
contracts, commitments, understandings, or arrangements by which
the Company is or may become bound to issue additional shares of
the capital stock of the Company or options, securities or rights
convertible into shares of capital stock of the Company. Except for
customary transfer restrictions contained in agreements entered
into by the Company in order to sell restricted securities or as
provided on Schedule 2.1(c) hereto, the Company is not a
party to or bound by any agreement or understanding granting
registration or anti-dilution rights to any person with respect to
any of its equity or debt securities. Except as set forth on
Schedule 2.1(c) , the Company is not a party to, and it has
no knowledge of, any agreement or understanding restricting the
voting or transfer of any shares of the capital stock of the
Company.
(d)
Issuance of Securities
. The Notes and the Warrants to be
issued have been duly authorized by all necessary corporate action
and, when paid for or issued in accordance with the terms hereof,
the Notes shall be validly issued and outstanding, free and clear
of all liens, encumbrances and rights of refusal of any kind. When
the Warrant Shares are issued and paid for in accordance with the
terms of this Agreement and as set forth in the Warrants, such
shares will be duly authorized by all necessary corporate action
and validly issued and outstanding, fully paid and non-assessable,
free and clear of all liens, encumbrances and rights of refusal of
any kind and the holders shall be entitled to all rights accorded
to a holder of Common Stock.
(e)
No Conflicts
. The execution, delivery and
performance of the Transaction Documents by the Company, the
performance by the Company of its obligations under the Notes and
the consummation by the Company of the transactions contemplated
hereby and thereby, and the issuance of the Securities as
contemplated hereby, do not and will not (i) violate or conflict
with any provision of the Company’s Certificate of
Incorporation (the “ Certificate ”) or Bylaws
(the “ Bylaws ”), each as amended to date, or
any Subsidiary’s comparable charter documents, (ii) conflict
with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to
others any rights of termination, amendment, acceleration or
cancellation of, any agreement, mortgage, deed of trust, indenture,
note, bond, license, lease agreement, instrument or obligation to
which the Company or any of its Subsidiaries is a party or by which
the Company or any of its Subsidiaries’ respective properties
or assets are bound, or (iii) result in a violation of any federal,
state, local or foreign statute, rule, regulation, order, judgment
or decree (including federal and state securities laws and
regulations) applicable to the Company or any of its Subsidiaries
or by which any property or asset of the Company or any of its
Subsidiaries are bound or affected, except, in all cases, for such
conflicts, defaults, terminations, amendments, acceleration,
cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect (other than violations
pursuant to clauses (i) or (iii) (with respect to federal and state
securities laws)). Neither the Company nor any of its Subsidiaries
is required under federal, state, foreign or local law, rule or
regulation to obtain any consent, authorization or order of, or
make any filing or registration with, any court or governmental
agency in order for it to execute, deliver or perform any of its
obligations under the Transaction Documents or issue and sell the
Securities in accordance with the terms hereof (other than any
filings, consents and approvals which may be required to be made by
the Company under applicable state and federal securities laws,
rules or regulations or any registration provisions provided in the
Registration Rights Agreement).
(f)
Commission Documents, Financial
Statements . The Common
Stock of the Company is registered pursuant to Section 12(b) or
12(g) of the Securities Exchange Act of 1934, as amended (the
“ Exchange Act ”), and the Company has timely
filed all reports, schedules, forms, statements and other documents
required to be filed by it with the Commission pursuant to the
reporting requirements of the Exchange Act (all of the foregoing
including filings incorporated by reference therein being referred
to herein as the “ Commission Documents ”). At
the times of their respective filings, the Form 10-Q for the fiscal
quarters ended March 31, 2006, June 30, 2006 and September 30, 2006
(collectively the “ Form 10-Q ”) and the Form
10-K for the fiscal year ended December 31, 2005 as filed on March
30, 2006, as amended on Form 10-K/A as filed on March 31, 2006
(collectively, the “ Form 10-K ”) complied in
all material respects with the requirements of the Exchange Act and
the rules and regulations of the Commission promulgated thereunder
and other federal, state and local laws, rules and regulations
applicable to such documents, and the Form 10-Q and Form 10-K did
not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances
under which they were made, not misleading. As of their respective
dates, the financial statements of the Company included in the
Commission Documents complied as to form in all material respects
with applicable accounting requirements and the published rules and
regulations of the Commission or other applicable rules and
regulations with respect thereto. Such financial statements have
been prepared in accordance with generally accepted accounting
principles (“ GAAP ”) applied on a consistent
basis during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the Notes thereto or (ii)
in the case of unaudited interim statements, to the extent they may
not include footnotes or may be condensed or summary statements),
and fairly present in all material respects the financial position
of the Company and its Subsidiaries as of the dates thereof and the
results of operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end
audit adjustments).
(g)
Subsidiaries
. Schedule 2.1(g) hereto sets
forth each Subsidiary of the Company, showing the jurisdiction of
its incorporation or organization and showing the percentage of
each person’s ownership of the outstanding stock or other
interests of such Subsidiary. For the purposes of this Agreement,
“ Subsidiary ” shall mean any corporation or
other entity of which at least a majority of the securities or
other ownership interest having ordinary voting power (absolutely
or contingently) for the election of directors or other persons
performing similar functions are at the time owned directly or
indirectly by the Company and/or any of its other Subsidiaries. All
of the outstanding shares of capital stock of each Subsidiary have
been duly authorized and validly issued, and are fully paid and
non-assessable. There are no outstanding preemptive, conversion or
other rights, options, warrants or agreements granted or issued by
or binding upon any Subsidiary for the purchase or acquisition of
any shares of capital stock of any Subsidiary or any other
securities convertible into, exchangeable for or evidencing the
rights to subscribe for any shares of such capital stock. Neither
the Company nor any Subsidiary is subject to any obligation
(contingent or otherwise) to repurchase or otherwise acquire or
retire any shares of the capital stock of any Subsidiary or any
convertible securities, rights, warrants or options of the type
described in the preceding sentence except as set forth on
Schedule 2.1(g) hereto. Neither the Company nor any
Subsidiary is party to, nor has any knowledge of, any agreement
restricting the voting or transfer of any shares of the capital
stock of any Subsidiary.
(h)
No Material Adverse
Change . Since September
30, 2006, the Company has not experienced or suffered any Material
Adverse Effect, except as disclosed on Schedule 2.1(h)
hereto.
(i)
No Undisclosed
Liabilities . Except as
disclosed on Schedule 2.1(i) hereto, neither the Company nor
any of its Subsidiaries has incurred any liabilities, obligations,
claims or losses (whether liquidated or unliquidated, secured or
unsecured, absolute, accrued, contingent or otherwise) other than
those incurred in the ordinary course of the Company’s or its
Subsidiaries respective businesses or which, individually or in the
aggregate, are not reasonably likely to have a Material Adverse
Effect.
(j)
No Undisclosed Events or
Circumstances . Since
September 30, 2006, except as disclosed on Schedule 2.1(j)
hereto, no event or circumstance has occurred or exists with
respect to the Company or its Subsidiaries or their respective
businesses, properties, prospects, operations or financial
condition, which, under applicable law, rule or regulation,
requires public disclosure or announcement by the Company but which
has not been so publicly announced or disclosed.
(k)
Indebtedness
. Schedule 2.1(k) hereto sets
forth as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the
Company or any Subsidiary has commitments. For the purposes of this
Agreement, “Indebtedness” shall mean (a) any
liabilities for borrowed money or amounts owed in excess of
$300,000 (other than trade accounts payable incurred in the
ordinary course of business), (b) all guaranties, endorsements and
other contingent obligations in respect of Indebtedness of others,
whether or not the same are or should be reflected in the
Company’s balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or
collection or similar transactions in the ordinary course of
business; and (c) the present value of any lease payments in excess
of $25,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in
default with respect to any Indebtedness.
(l)
Title to Assets
. Each of the Company and the
Subsidiaries has good and valid title to all of its real and
personal property reflected in the Commission Documents, free and
clear of any mortgages, pledges, charges, liens, security interests
or other encumbrances, except for those indicated on Schedule
2.1(l) hereto or such that, individually or in the aggregate,
do not cause a Material Adverse Effect. All said leases of the
Company and each of its Subsidiaries are valid and subsisting and
in full force and effect.
(m)
Actions Pending
. There is no action, suit, claim,
investigation, arbitration, alternate dispute resolution proceeding
or other proceeding pending or, to the knowledge of the Company,
threatened against the Company or any Subsidiary which questions
the validity of this Agreement or any of the other Transaction
Documents or any of the transactions contemplated hereby or thereby
or any action taken or to be taken pursuant hereto or thereto.
Except as set forth on Schedule 2.1(m) hereto, there is no
action, suit, claim, investigation, arbitration, alternate dispute
resolution proceeding or other proceeding pending or, to the
knowledge of the Company, threatened against or involving the
Company, any Subsidiary or any of their respective properties or
assets, which individually or in the aggregate, would reasonably be
expected, if adversely determined, to have a Material Adverse
Effect. There are no outstanding orders, judgments, injunctions,
awards or decrees of any court, arbitrator or governmental or
regulatory body against the Company or any Subsidiary or any
officers or directors of the Company or Subsidiary in their
capacities as such, which individually or in the aggregate, could
reasonably be expected to have a Material Adverse
Effect.
(n)
Compliance with Law
. The business of the Company and
the Subsidiaries has been and is presently being conducted in
accordance with all applicable federal, state and local
governmental laws, rules, regulations and ordinances, except as set
forth in the Commission Documents or on Schedule 2.1(n)
hereto or such that, individually or in the aggregate, the
noncompliance therewith could not reasonably be expected to have a
Material Adverse Effect. The Company and each of its Subsidiaries
have all franchises, permits, licenses, consents and other
governmental or regulatory authorizations and approvals necessary
for the conduct of its business as now being conducted by it unless
the failure to possess such franchises, permits, licenses, consents
and other governmental or regulatory authorizations and approvals,
individually or in the aggregate, could not reasonably be expected
to have a Material Adverse Effect.
(o)
Taxes . The Company and each of the Subsidiaries has
accurately prepared and filed all federal, state and other tax
returns required by law to be filed by it, has paid or made
provisions for the payment of all taxes shown to be due and all
additional assessments, and adequate provisions have been and are
reflected in the financial statements of the Company and the
Subsidiaries for all current taxes and other charges to which the
Company or any Subsidiary is subject and which are not currently
due and payable. Except as disclosed on Schedule 2.1(o)
hereto, none of the federal income tax returns of the Company or
any Subsidiary have been audited by the Internal Revenue Service.
The Company has no knowledge of any additional assessments,
adjustments or contingent tax liability (whether federal or state)
of any nature whatsoever, whether pending or threatened against the
Company or any Subsidiary for any period, nor of any basis for any
such assessment, adjustment or contingency.
(p)
Certain Fees
. Except as set forth on Schedule
2.1(p) hereto, the Company has not employed any broker or
finder or incurred any liability for any brokerage or investment
banking fees, commissions, finders’ structuring fees,
financial advisory fees or other similar fees in connection with
the Transaction Documents.
(q)
Disclosure
. To the best of the Company’s
knowledge, neither this Agreement or the Schedules hereto nor any
other documents, certificates or instruments furnished to the
Purchasers by or on behalf of the Company or any Subsidiary in
connection with the transactions contemplated by this Agreement
contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements made herein
or therein, in the light of the circumstances under which they were
made herein or therein, not misleading.
(r)
Operation of Business
. Except as set forth on Schedule
2.1(r) hereto, the Company and each of the Subsidiaries owns or
possesses the rights to all patents, trademarks, domain names
(whether or not registered) and any patentable improvements or
copyrightable derivative works thereof, websites and intellectual
property rights relating thereto, service marks, trade names,
copyrights, licenses and authorizations which are necessary for the
conduct of its business as now conducted without any conflict with
the rights of others.
(s)
Environmental
Compliance . The Company
and each of its Subsidiaries have obtained all material approvals,
authorization, certificates, consents, licenses, orders and permits
or other similar authorizations of all governmental authorities, or
from any other person, that are required under any Environmental
Laws. “Environmental Laws” shall mean all applicable
laws relating to the protection of the environment including,
without limitation, all requirements pertaining to reporting,
licensing, permitting, controlling, investigating or remediating
emissions, discharges, releases or threatened releases of hazardous
substances, chemical substances, pollutants, contaminants or toxic
substances, materials or wastes, whether solid, liquid or gaseous
in nature, into the air, surface water, groundwater or land, or
relating to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of hazardous
substances, chemical substances, pollutants, contaminants or toxic
substances, material or wastes, whether solid, liquid or gaseous in
nature. To the best of the Company’s knowledge, the Company
has all necessary governmental approvals required under all
Environmental Laws as necessary for the Company’s business or
the business of any of its subsidiaries. To the best of the
Company’s knowledge, the Company and each of its subsidiaries
are also in compliance with all other limitations, restrictions,
conditions, standards, requirements, schedules and timetables
required or imposed under all Environmental Laws. Except for such
instances as would not individually or in the aggregate have a
Material Adverse Effect, there are no past or present events,
conditions, circumstances, incidents, actions or omissions relating
to or in any way affecting the Company or its subsidiaries that
violate or may violate any Environmental Law after the Closing Date
or that may give rise to any environmental liability, or otherwise
form the basis of any claim, action, demand, suit, proceeding,
hearing, study or investigation (i) under any Environmental Law, or
(ii) based on or related to the manufacture, processing,
distribution, use, treatment, storage (including without limitation
underground storage tanks), disposal, transport or handling, or the
emission, discharge, release or threatened release of any hazardous
substance.
(t)
Books and Records; Internal
Accounting Controls . The
records and documents of the Company and its Subsidiaries
accurately reflect in all material respects the information
relating to the business of the Company and the Subsidiaries, the
location and collection of their assets, and the nature of all
transactions giving rise to the obligations or accounts receivable
of the Company or any Subsidiary. The Company and each of its
Subsidiaries maintain a system of internal accounting controls
sufficient, in the judgment of the Company’s board of
directors, to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or
specific authorizations, (ii) transactions are recorded as
necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to
maintain asset accountability, (iii) access to assets is permitted
only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and
appropriate actions are taken with respect to any
differences.
(u)
Material Agreements
. Except for the Transaction
Documents (with respect to clause (i) only), as disclosed in the
Commission Documents or as set forth on Schedule 2.1(u)
hereto, or as would not be reasonably likely to have a Material
Adverse Effect, (i) the Company and each of its Subsidiaries have
performed all obligations required to be performed by them to date
under any written or oral contract, instrument, agreement,
commitment, obligation, plan or arrangement, filed or required to
be filed with the Commission (the “ Material
Agreements ”), (ii) neither the Company nor any of its
Subsidiaries has received any notice of default under any Material
Agreement and, (iii) to the best of the Company’s knowledge,
neither the Company nor any of its Subsidiaries is in default under
any Material Agreement now in effect.
(v)
Transactions with
Affiliates . Except as
set forth on Schedule 2.1(v) hereto and in the Commission
Documents, there are no loans, leases, agreements, contracts,
royalty agreements, management contracts or arrangements or other
continuing transactions between (a) the Company, any Subsidiary or
any of their respective customers or suppliers on the one hand, and
(b) on the other hand, any officer, employee, consultant or
director of the Company, or any of its Subsidiaries, or any person
owning at least 5% of the outstanding capital stock of the Company
or any Subsidiary or any member of the immediate family of such
officer, employee, consultant, director or stockholder or any
corporation or other entity controlled by such officer, employee,
consultant, director or stockholder, or a member of the immediate
family of such officer, employee, consultant, director or
stockholder which, in each case, is required to be disclosed in the
Commission Documents or in the Company’s most recently filed
definitive proxy statement on Schedule 14A, that is not so
disclosed in the Commission Documents or in such proxy
statement.
(w)
Securities Act of 1933
. Based in material part upon the
representations herein of the Purchasers, the Company has complied
and will comply with all applicable federal and state securities
laws in connection with the offer, issuance and sale of the
Securities hereunder. Neither the Company nor anyone acting on its
behalf, directly or indirectly, has or will sell, offer to sell or
solicit offers to buy any of the Securities or similar securities
to, or solicit offers with respect thereto from, or enter into any
negotiations relating thereto with, any person, or has taken or
will take any action so as to bring the issuance and sale of any of
the Securities under the registration provisions of the Securities
Act and applicable state securities laws, and neither the Company
nor any of its affiliates, nor any person acting on its or their
behalf, has engaged in any form of general solicitation or general
advertising (within the meaning of Regulation D under the
Securities Act) in connection with the offer or sale of any of the
Securities.
(x)
Employees . Neither the Company nor any Subsidiary has any
collective bargaining arrangements or agreements covering any of
its employees, except as set forth on Schedule 2.1(x)
hereto. Except as set forth on Schedule 2.1(x) hereto,
neither the Company nor any Subsidiary has any employment contract,
agreement regarding proprietary information, non-competition
agreement, non-solicitation agreement, confidentiality agreement,
or any other similar contract or restrictive covenant, relating to
the right of any officer, employee or consultant to be employed or
engaged by the Company or such Subsidiary required to be disclosed
in the Commission Documents that is not so disclosed. No
|